Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2016-06-23 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
关于为全资子公司银行授信提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company providing a guarantee for a bank credit facility to its wholly-owned subsidiary. It details the board meeting approval, the terms of the guarantee, and the financial status of the subsidiary. The document is relatively short (1516 characters) and focuses on a specific financing-related event (providing a guarantee for a loan). It is not a full financial report, audit, or earnings release. It is not a report publication announcement or certification. The content fits best under Capital/Financing Update (CAP) as it relates to financing activities and guarantees provided by the company.
2016-06-23 Chinese
关于核销部分应收账款的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from the company regarding the write-off of certain accounts receivable. It includes details about the amounts, accounting standards applied, and opinions from the board, supervisory committee, and independent directors. The document does not contain comprehensive financial statements or detailed financial performance data typical of an Annual Report or Interim Report. It is a specific corporate announcement about an accounting action (write-off of receivables) approved by the board. This fits best under Regulatory Filings (RNS) as it is a regulatory announcement about a financial matter but not a full financial report or audit report.
2016-06-23 Chinese
关于召开2015年度股东大会的提示性公告
AGM Information Classification · 100% confidence The document is a detailed announcement about the convening of the 2015 Annual General Meeting (AGM) of the company 启迪古汉集团股份有限公司. It includes information about the meeting date, voting methods (both onsite and online), agenda items to be discussed and voted on, registration procedures, and voting instructions. The document does not contain the actual annual report or financial statements but rather serves as a notice and guide for shareholders to participate in the AGM. It also includes attachments such as the proxy form and voting procedures. This fits the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or notices about the AGM itself. The document length is sufficient and detailed, confirming it is not a brief report publication announcement or a simple regulatory filing. Therefore, the correct classification is AGM Information (AGM-R).
2016-06-20 Chinese
附条件生效的股份认购合同之补充合同（三）
Capital/Financing Update Classification · 95% confidence The document is a supplementary contract related to a conditional share subscription agreement between a company and an investment fund. It details the subscription amounts, involved parties, and the sources of funds for a non-public issuance of A shares. The content focuses on the terms and conditions of a capital raising transaction, specifically a private placement of shares to a strategic investor. There are no financial statements, audit opinions, or management discussions of financial results. The document is not an announcement of a report but a contractual agreement related to capital raising. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length and detail support this classification with high confidence.
2016-06-15 Chinese
附条件生效的股份认购合同之补充合同（一）
Capital/Financing Update Classification · 95% confidence The document is titled as a supplementary contract to a conditional share subscription agreement between two parties, involving a non-public issuance of A shares. It details terms about the subscription funds, breach of contract liabilities, and legal effect of the supplementary contract. There is no indication of financial statements, regulatory filings, or report announcements. The content is related to capital raising and share subscription agreements, which aligns with updates on company fundraising or capital structure changes. The document length is short (1712 characters), and it is a contract supplement rather than a report or announcement. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2016-06-15 Chinese
嘉实基金-工商银行-元寿二号资产管理合同
Regulatory Filings Classification · 95% confidence The document is a detailed asset management contract between an asset entrusting party, an asset management company, and an asset custodian. It includes sections on definitions, rights and obligations of parties, investment policies, investment manager designation, investment instructions, trading and settlement arrangements, and valuation of entrusted assets. The content is contractual and operational in nature, focusing on the management and custody of assets, investment strategies, and compliance with laws and regulations. There is no indication that this is an annual report, audit report, earnings release, or any other financial report. It is not a regulatory filing or announcement but a formal contract document. Given the nature of the document as an asset management contract, it best fits under the category of Regulatory Filings (RNS) as a fallback for documents that do not neatly fit into other categories, since there is no specific category for asset management contracts in the provided list.
2016-06-15 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.